First Citizens Bank & Trust Co. lessened its holdings in Teleflex Incorporated (NYSE:TFX) by 23.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,771 shares of the medical technology company’s stock after selling 543 shares during the quarter. First Citizens Bank & Trust Co.’s holdings in Teleflex were worth $441,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also modified their holdings of TFX. Janus Henderson Group PLC boosted its holdings in Teleflex by 50,429.2% in the second quarter. Janus Henderson Group PLC now owns 1,816,020 shares of the medical technology company’s stock worth $377,296,000 after acquiring an additional 1,812,426 shares in the last quarter. Koch Industries Inc. boosted its holdings in Teleflex by 47,174.3% in the second quarter. Koch Industries Inc. now owns 959,669 shares of the medical technology company’s stock worth $955,000 after acquiring an additional 957,639 shares in the last quarter. American Century Companies Inc. boosted its holdings in Teleflex by 41.6% in the third quarter. American Century Companies Inc. now owns 1,187,909 shares of the medical technology company’s stock worth $287,438,000 after acquiring an additional 348,829 shares in the last quarter. Mackay Shields LLC acquired a new stake in Teleflex in the third quarter worth about $29,644,000. Finally, Atlanta Capital Management Co. L L C boosted its holdings in Teleflex by 2.6% in the second quarter. Atlanta Capital Management Co. L L C now owns 2,519,464 shares of the medical technology company’s stock worth $523,444,000 after acquiring an additional 64,985 shares in the last quarter. 89.29% of the stock is owned by institutional investors and hedge funds.
Shares of Teleflex Incorporated (NYSE:TFX) opened at $263.18 on Friday. The company has a current ratio of 4.72, a quick ratio of 3.70 and a debt-to-equity ratio of 0.88. Teleflex Incorporated has a twelve month low of $162.79 and a twelve month high of $271.23. The company has a market capitalization of $11,620.00, a PE ratio of 47.51, a P/E/G ratio of 1.90 and a beta of 1.09.
The company also recently announced a quarterly dividend, which was paid on Friday, December 15th. Investors of record on Wednesday, November 15th were issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.52%. The ex-dividend date of this dividend was Tuesday, November 14th. Teleflex’s dividend payout ratio (DPR) is 24.55%.
Several brokerages have weighed in on TFX. Morgan Stanley raised their price target on Teleflex from $274.00 to $290.00 and gave the stock an “equal weight” rating in a report on Friday, November 3rd. Deutsche Bank downgraded Teleflex from a “buy” rating to a “hold” rating and set a $251.00 price target for the company. in a report on Tuesday, November 14th. Zacks Investment Research raised Teleflex from a “hold” rating to a “buy” rating and set a $265.00 price target for the company in a report on Friday, September 22nd. Needham & Company LLC raised their price target on Teleflex from $237.00 to $285.00 and gave the stock a “buy” rating in a report on Friday, November 3rd. Finally, Jefferies Group raised their price target on Teleflex from $270.00 to $295.00 and gave the stock a “buy” rating in a report on Friday, November 3rd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $274.44.
In related news, Director Stephen K. M.D. Klasko sold 200 shares of Teleflex stock in a transaction that occurred on Tuesday, January 2nd. The stock was sold at an average price of $248.96, for a total transaction of $49,792.00. Following the completion of the transaction, the director now directly owns 8,080 shares in the company, valued at $2,011,596.80. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Benson Smith sold 2,000 shares of Teleflex stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $258.10, for a total value of $516,200.00. Following the transaction, the chief executive officer now owns 76,634 shares of the company’s stock, valued at $19,779,235.40. The disclosure for this sale can be found here. Insiders have sold 2,600 shares of company stock valued at $666,492 in the last ninety days. Corporate insiders own 2.39% of the company’s stock.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.